Agonist-specific FPR1 conformational change prevents receptor recycling and promotes targeted protein degradation
Acta Pharmaceutica Sinica B · 2026-05 · 16 (5) · 3043-3058
DOI: 10.1016/j.apsb.2026.03.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-05. Verfasst von Junlin Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecule…. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shenzhen Basic Research Program, National Natural Science Foundation of China, Fund for the Development of Science and Technology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs/Guangdong Province Key Laboratory…
- Kobilka Institute of Innovative Drug Discovery, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.
- Department of Food Science and Nutrition, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR 999077, China.
- School of Medicine, Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen 518107, China.
- State Key Laboratory of Mechanism and Quality of Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR 999078, China.
- Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, University of Macau, Macau SAR 999078, China.
Förderung
- Shenzhen Basic Research Program
- National Natural Science Foundation of China
- Fund for the Development of Science and Technology
- China Postdoctoral Science Foundation
- Yunnan Key Research and Development Program
- College of Medicine, University of Oklahoma
Zitieren
APA
Wang, J., Liao, Q., Chen, G., Chang, Y., Nie, H., Lu, J., & Ye, R. D. (2026). Agonist-specific FPR1 conformational change prevents receptor recycling and promotes targeted protein degradation. Acta Pharmaceutica Sinica B, 16(5), 3043-3058. https://doi.org/10.1016/j.apsb.2026.03.019
Vancouver
Wang J, Liao Q, Chen G, Chang Y, Nie H, Lu J, et al. Agonist-specific FPR1 conformational change prevents receptor recycling and promotes targeted protein degradation. Acta Pharmaceutica Sinica B. 2026;16(5):3043-3058. doi:10.1016/j.apsb.2026.03.019
BibTeX
@article{Wang2026,
author = {Wang, Junlin and Liao, Qiwen and Chen, Geng and Chang, Yixin and Nie, Hong and Lu, Jiahong and Ye, Richard D},
title = {Agonist-specific FPR1 conformational change prevents receptor recycling and promotes targeted protein degradation},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
volume = {16},
number = {5},
pages = {3043--3058},
doi = {10.1016/j.apsb.2026.03.019}
}
EUVIMED